Seneca Growth Capital VCT PLC (HYG) - Net Assets
Based on the latest financial reports, Seneca Growth Capital VCT PLC (HYG) has net assets worth GBX13.94 Million GBX (≈ $1.70K USD) as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX14.16 Million ≈ $1.72K USD) and total liabilities (GBX219.00K ≈ $26.65 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Seneca Growth Capital VCT PLC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX13.94 Million |
| % of Total Assets | 98.45% |
| Annual Growth Rate | 3.37% |
| 5-Year Change | 29.42% |
| 10-Year Change | 127.41% |
| Growth Volatility | 29.56 |
Seneca Growth Capital VCT PLC - Net Assets Trend (2002–2024)
This chart illustrates how Seneca Growth Capital VCT PLC's net assets have evolved over time, based on quarterly financial data. See Seneca Growth Capital VCT PLC liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Seneca Growth Capital VCT PLC (2002–2024)
The table below shows the annual net assets of Seneca Growth Capital VCT PLC from 2002 to 2024. For live valuation and market cap data, see HYG company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX13.94 Million ≈ $1.70K |
-17.49% |
| 2023-12-31 | GBX16.89 Million ≈ $2.06K |
-6.83% |
| 2022-12-31 | GBX18.13 Million ≈ $2.21K |
+2.07% |
| 2021-12-31 | GBX17.76 Million ≈ $2.16K |
+64.93% |
| 2020-12-31 | GBX10.77 Million ≈ $1.31K |
+28.46% |
| 2019-12-31 | GBX8.38 Million ≈ $1.02K |
-9.66% |
| 2018-12-31 | GBX9.28 Million ≈ $1.13K |
+79.17% |
| 2017-12-31 | GBX5.18 Million ≈ $630.26 |
-6.62% |
| 2016-12-31 | GBX5.55 Million ≈ $674.91 |
-9.50% |
| 2015-12-31 | GBX6.13 Million ≈ $745.72 |
-16.43% |
| 2014-12-31 | GBX7.33 Million ≈ $892.34 |
-6.32% |
| 2013-12-31 | GBX7.83 Million ≈ $952.56 |
-18.40% |
| 2012-12-31 | GBX9.59 Million ≈ $1.17K |
+67.35% |
| 2011-12-31 | GBX5.73 Million ≈ $697.54 |
-8.74% |
| 2010-12-31 | GBX6.28 Million ≈ $764.34 |
-15.15% |
| 2009-12-31 | GBX7.40 Million ≈ $900.85 |
+43.63% |
| 2008-12-31 | GBX5.16 Million ≈ $627.21 |
+11.87% |
| 2007-12-31 | GBX4.61 Million ≈ $560.66 |
+7.31% |
| 2006-12-31 | GBX4.29 Million ≈ $522.46 |
-24.39% |
| 2005-12-31 | GBX5.68 Million ≈ $690.97 |
-9.79% |
| 2004-12-31 | GBX6.29 Million ≈ $765.92 |
-8.91% |
| 2003-12-31 | GBX6.91 Million ≈ $840.87 |
+2.74% |
| 2002-12-31 | GBX6.73 Million ≈ $818.48 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Seneca Growth Capital VCT PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX324.00K | 2.32% |
| Other Components | GBX13.61 Million | 97.68% |
| Total Equity | GBX13.94 Million | 100.00% |
Seneca Growth Capital VCT PLC Competitors by Market Cap
The table below lists competitors of Seneca Growth Capital VCT PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PTT Global Chemical Public Company Limited
F:GCB
|
$8.97K |
|
BANGCHAK CORP. -FGN- BA 1
F:7BP
|
$9.28K |
|
MIRIS HOLDING AB O.N.
F:9W4
|
$9.35K |
|
Next.e.GO N.V.
NASDAQ:EGOXF
|
$9.44K |
|
YUMY CANDY COMPANY INC.
F:FWR0
|
$8.76K |
|
Yeh-Chiang Technology
TWO:6124
|
$8.75K |
|
KRUNGTHAI CARD FGN BA 1
F:KRTA
|
$8.58K |
|
Carisma Therapeutics Inc.
NASDAQ:CARM
|
$8.37K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Seneca Growth Capital VCT PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 16,892,000 to 13,938,000, a change of -2,954,000 (-17.5%).
- Net loss of 3,742,000 reduced equity.
- Dividend payments of 717,000 reduced retained earnings.
- Share repurchases of 164,000 reduced equity.
- New share issuances of 1,669,000 increased equity.
- Other comprehensive income decreased equity by 18,571,000.
- Other factors increased equity by 18,571,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-3.74 Million | -26.85% |
| Dividends Paid | GBX717.00K | -5.14% |
| Share Repurchases | GBX164.00K | -1.18% |
| Share Issuances | GBX1.67 Million | +11.97% |
| Other Comprehensive Income | GBX-18.57 Million | -133.24% |
| Other Changes | GBX18.57 Million | +133.24% |
| Total Change | GBX- | -17.49% |
Book Value vs Market Value Analysis
This analysis compares Seneca Growth Capital VCT PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 20.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 7.75x to 20.17x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | GBX1.16 | GBX9.00 | x |
| 2003-12-31 | GBX0.94 | GBX9.00 | x |
| 2004-12-31 | GBX0.83 | GBX9.00 | x |
| 2005-12-31 | GBX0.75 | GBX9.00 | x |
| 2006-12-31 | GBX0.57 | GBX9.00 | x |
| 2007-12-31 | GBX0.61 | GBX9.00 | x |
| 2008-12-31 | GBX0.67 | GBX9.00 | x |
| 2009-12-31 | GBX0.92 | GBX9.00 | x |
| 2010-12-31 | GBX0.77 | GBX9.00 | x |
| 2011-12-31 | GBX0.71 | GBX9.00 | x |
| 2012-12-31 | GBX1.18 | GBX9.00 | x |
| 2013-12-31 | GBX0.96 | GBX9.00 | x |
| 2014-12-31 | GBX0.90 | GBX9.00 | x |
| 2015-12-31 | GBX0.76 | GBX9.00 | x |
| 2016-12-31 | GBX0.68 | GBX9.00 | x |
| 2017-12-31 | GBX0.64 | GBX9.00 | x |
| 2018-12-31 | GBX1.14 | GBX9.00 | x |
| 2019-12-31 | GBX0.63 | GBX9.00 | x |
| 2020-12-31 | GBX1.07 | GBX9.00 | x |
| 2021-12-31 | GBX1.07 | GBX9.00 | x |
| 2022-12-31 | GBX0.73 | GBX9.00 | x |
| 2023-12-31 | GBX0.60 | GBX9.00 | x |
| 2024-12-31 | GBX0.45 | GBX9.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Seneca Growth Capital VCT PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -26.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: -0.24x
- • Equity Multiplier: 1.02x
- Recent ROE (-26.85%) is below the historical average (-4.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.85% | 29.08% | 0.03x | 1.01x | GBX-615.70K |
| 2003 | 0.56% | 17.03% | 0.03x | 1.02x | GBX-652.10K |
| 2004 | -0.10% | 0.00% | 0.00x | 1.01x | GBX-635.50K |
| 2005 | -5.71% | 0.00% | 0.00x | 1.02x | GBX-891.90K |
| 2006 | -3.89% | 0.00% | 0.00x | 1.01x | GBX-596.40K |
| 2007 | -3.56% | -32.35% | 0.11x | 1.01x | GBX-624.80K |
| 2008 | -2.39% | -22.20% | 0.11x | 1.01x | GBX-638.50K |
| 2009 | -0.23% | -0.77% | 0.30x | 1.00x | GBX-757.40K |
| 2010 | -2.13% | -50.57% | 0.04x | 1.00x | GBX-762.20K |
| 2011 | -1.50% | -1228.57% | 0.00x | 1.01x | GBX-659.30K |
| 2012 | -1.63% | -2.99% | 0.48x | 1.13x | GBX-1.12 Million |
| 2013 | -2.09% | -1490.91% | 0.00x | 1.11x | GBX-946.90K |
| 2014 | -2.06% | -1258.33% | 0.00x | 1.10x | GBX-884.40K |
| 2015 | -19.66% | 0.00% | -0.16x | 1.08x | GBX-1.82 Million |
| 2016 | -10.49% | 0.00% | -0.10x | 1.09x | GBX-1.14 Million |
| 2017 | -7.08% | 0.00% | -0.06x | 1.08x | GBX-885.00K |
| 2018 | 0.71% | 36.87% | 0.02x | 1.05x | GBX-862.10K |
| 2019 | -8.53% | 0.00% | -0.07x | 1.03x | GBX-1.55 Million |
| 2020 | 12.04% | 89.51% | 0.13x | 1.04x | GBX220.00K |
| 2021 | 11.80% | 92.46% | 0.12x | 1.03x | GBX319.70K |
| 2022 | -15.16% | 0.00% | -0.14x | 1.03x | GBX-4.56 Million |
| 2023 | -15.81% | 0.00% | -0.14x | 1.02x | GBX-4.36 Million |
| 2024 | -26.85% | 0.00% | -0.24x | 1.02x | GBX-5.14 Million |
Industry Comparison
This section compares Seneca Growth Capital VCT PLC's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $657,704,100
- Average return on equity (ROE) among peers: 5.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Seneca Growth Capital VCT PLC (HYG) | GBX13.94 Million | 0.85% | 0.02x | $8.89K |
| 3I Infrastructure PLC (3IN) | $1.25 Billion | 6.43% | 0.14x | $41.69 Million |
| Albion Enterprise VCT PLC (AAEV) | $140.65 Million | 2.37% | 0.01x | $3.29 Million |
| abrdn Asian Income Fund Limited (AAIF) | $154.40 Million | 26.46% | 0.07x | $5.95 Million |
| Abrdn Asia Focus PLC (AAS) | $121.96 Million | 12.34% | 0.07x | $7.74 Million |
| Albion Technology & General VCT PLC (AATG) | $121.25 Million | -5.20% | 0.01x | $3.15 Million |
| Abrdn PLC (ABDN) | $3.74 Billion | 2.67% | 35.62x | $50.56 Million |
| Aberdeen Diversified Income and Growth Trust PLC (ADIG) | $428.13 Million | 2.15% | 0.15x | $450.86K |
| Aquila Energy Efficiency Trust PLC (AEET) | $97.38 Million | -0.64% | 0.00x | $247.72K |
| Aquila European Renewables Income PLC (AERI) | $372.54 Million | -8.03% | 0.00x | $56.72 Million |
| Artemis UK Future Leaders plc (AFL) | $152.03 Million | 18.55% | 0.02x | $404.11 |
About Seneca Growth Capital VCT PLC
Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gro… Read more